Adaptive Embolic Particles for Specialized Environments
Legal Citation
Summary of the Inventive Concept
A system of embolic particles designed for deployment in unique operational environments, including high-altitude, emergency response, high-security, underwater, and extreme weather conditions, addressing the limitations of traditional embolic particles in these settings.
Background and Problem Solved
The original patent describes embolic particles for general medical purposes, but these particles may not be suitable for use in specialized environments. For instance, high-altitude environments require particles that expand in response to low atmospheric pressure, while emergency response situations demand rapid deployment. The new inventive concept addresses these limitations by providing adaptive embolic particles tailored to specific operational environments.
Detailed Description of the Inventive Concept
The inventive concept comprises embolic particles with unique properties and functionalities adapted to specific environments. For high-altitude embolization, the particles expand in size upon exposure to low atmospheric pressure. In emergency response situations, the particles are designed for rapid deployment through a microcatheter. The high-security embolic device features particles resistant to tampering or unauthorized access. The underwater embolization system incorporates buoyant particles that expand in response to water pressure. The extreme weather embolization method utilizes particles that withstand extreme temperatures and weather conditions. These adaptive particles can be delivered through a microcatheter, ensuring effective occlusion of vascular defects in these specialized environments.
Novelty and Inventive Step
The new claims introduce novel adaptations of embolic particles for specific operational environments, which are not obvious from the original patent. The inventive step lies in the tailored design of particles to address the unique challenges of high-altitude, emergency response, high-security, underwater, and extreme weather environments.
Alternative Embodiments and Variations
Alternative embodiments may include particles with adjustable expansion rates, particles that change shape in response to environmental cues, or particles with integrated sensors for real-time monitoring. Variations may also include different materials, shapes, or sizes of particles to accommodate diverse operational environments.
Potential Commercial Applications and Market
The adaptive embolic particles have significant commercial potential in various industries, including medical devices, emergency response, aerospace, and defense. The target market includes hospitals, emergency responders, and military organizations operating in specialized environments.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61L24/06 |
| A | A61 | A61L24/001 |
| C | C08 | C08F222/385 |
| A | A61 | A61L2430/36 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device engineering, specifically interventional medical particles for vascular occlusion, requiring expertise in polymer chemistry, medical device design, and microcatheter-compatible particle fabrication
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or materials scientist with advanced degree, experience in polymer synthesis, medical device development, and understanding of microcatheter delivery systems for minimally invasive medical interventions
Obviousness Rationale
A PHOSITA would recognize that the PTD's environmental adaptations represent predictable variations of the source patent's core embolic particle technology. The fundamental design principles of size-adjustable, microcatheter-deliverable particles remain consistent across the PTD's proposed variations. The specific environmental modifications represent routine engineering adaptations that would be apparent to a skilled practitioner seeking to expand the utility of embolic particle systems.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,694 |
|---|---|
| Title | Particles |
| Assignee(s) | MicroVention, Inc. |